ArticleAlimentary pharmacology & therapeutics2021
Editorial: evolution of GLP-1 receptor agonists as pharmacotherapy for NASH beyond diabetes mellitus and obesity - authors' reply.
Anne Flint et al.PubMed ↗Publisher ↗
No numbers read from the abstract.